Gabapentin

Generic: Gabapentin

Labeler: REMEDYREPACK INC.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Active

Drug Facts

Product Profile

Brand Name Gabapentin
Generic Name Gabapentin
Labeler REMEDYREPACK INC.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

GABAPENTIN 800 mg/1

Identifiers & Regulatory

Product NDC 70518-2912
Product ID 70518-2912_3dd1e7cf-d615-675f-e063-6394a90ad3e0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206402
Listing Expiration 2026-12-31
Marketing Start 2020-10-20

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705182912
Hyphenated Format 70518-2912

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Gabapentin (source: ndc)
Generic Name Gabapentin (source: ndc)
Application Number ANDA206402 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/1
source: ndc
Packaging
  • 100 POUCH in 1 BOX (70518-2912-0) / 1 TABLET in 1 POUCH (70518-2912-1)
  • 100 POUCH in 1 BOX (70518-2912-2) / 1 TABLET in 1 POUCH (70518-2912-3)
source: ndc

Packages (2)

Ingredients (1)

GABAPENTIN (800 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3dd1e7cf-d615-675f-e063-6394a90ad3e0", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310434"], "spl_set_id": ["bc525ae4-9843-4038-a1b7-0d3543e2282c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "100 POUCH in 1 BOX (70518-2912-0)  / 1 TABLET in 1 POUCH (70518-2912-1)", "package_ndc": "70518-2912-0", "marketing_start_date": "20201020"}, {"sample": false, "description": "100 POUCH in 1 BOX (70518-2912-2)  / 1 TABLET in 1 POUCH (70518-2912-3)", "package_ndc": "70518-2912-2", "marketing_start_date": "20230319"}], "brand_name": "Gabapentin", "product_id": "70518-2912_3dd1e7cf-d615-675f-e063-6394a90ad3e0", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-2912", "generic_name": "Gabapentin", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA206402", "marketing_category": "ANDA", "marketing_start_date": "20201020", "listing_expiration_date": "20261231"}